Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 17, 2017 - Issue 5
Submit an article Journal homepage
287
Views
30
CrossRef citations to date
0
Altmetric
Review

Immunological aspects of botulinum toxin therapy

Dirk DresslerMovement Disorders Section, Department of Neurology, Hannover Medical School, Hannover, GermanyCorrespondence[email protected]
View further author information
&
Hans BigalkeToxogen, Hannover, GermanyView further author information
Pages 487-494 | Received 26 Jan 2016, Accepted 15 Nov 2016, Published online: 28 Nov 2016

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Luca Marsili, Matteo Bologna, Joseph Jankovic & Carlo Colosimo. (2021) Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal. Expert Opinion on Drug Safety 20:6, pages 695-705.
Read now
Stanley Evander Emeltan Tjoa, Yoanes Maria Vianney & Sulistyo Emantoko Dwi Putra. (2019) In silico mutagenesis: decreasing the immunogenicity of botulinum toxin type A. Journal of Biomolecular Structure and Dynamics 37:18, pages 4767-4778.
Read now

Articles from other publishers (28)

Dirk Dressler, John C. Rothwell, Kailash Bhatia, Bruno Kopp, Hans Bigalke & Fereshte Adib Saberi. (2022) Botulinum toxin antibody titres: measurement, interpretation, and practical recommendations. Journal of Neurology 270:3, pages 1524-1530.
Crossref
Dirk Dressler, Hans Bigalke & Jürgen Frevert. (2022) The immunology of botulinum toxin therapy: A brief summary. Toxicology 481, pages 153341.
Crossref
Nadia Hammoud & Joseph Jankovic. (2022) Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based Review. Dystonia 1.
Crossref
Chen Xue, Chengzhi Jiang, Yuanyuan Zhu, Xiaobo Liu, Dongling Zhong, Yuxi Li, Huiling Zhang, Wenjing Tang, Jian She, Cheng Xie, Juan Li, Yue Feng & Rongjiang Jin. (2022) Effectiveness and safety of acupuncture for post-stroke spasticity: A systematic review and meta-analysis. Frontiers in Neurology 13.
Crossref
Hui-Ling Zhang, Rong-Jiang Jin, Li Guan, Dong-Ling Zhong, Yu-Xi Li, Xiao-Bo Liu, Qi-Wei Xiao, Xi-Li Xiao & Juan Li. (2022) Extracorporeal Shock Wave Therapy on Spasticity After Upper Motor Neuron Injury. American Journal of Physical Medicine & Rehabilitation 101:7, pages 615-623.
Crossref
Dirk Dressler & Eric A. Johnson. (2022) Botulinum toxin therapy: past, present and future developments. Journal of Neural Transmission 129:5-6, pages 829-833.
Crossref
Je-Young Park, Niamh Corduff, Jürgen Frevert, Rungsima Wanitphakdeedecha & Yates Y.Y. Chao. (2022) Immunogenicity Associated with Aesthetic Botulinumtoxin A: A Survey of Asia-Pacific Physicians’ Experiences and Recommendations. Plastic and Reconstructive Surgery - Global Open 10:4, pages e4217.
Crossref
Syeo Young Wee & Eun Soo Park. (2022) Immunogenicity of botulinum toxin. Archives of Plastic Surgery 49:01, pages 12-18.
Crossref
亚辉 秦. (2022) Advances in Application of Botulinum Toxin Type A in Neurology. Advances in Clinical Medicine 12:03, pages 1679-1685.
Crossref
Raja Mehanna & Joseph Jankovic. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity 1095 1143 .
Dirk Dressler, Lizhen Pan, Junhui Su, Fei Teng & Lingjing Jin. (2021) Lantox—The Chinese Botulinum Toxin Drug—Complete English Bibliography and Comprehensive Formalised Literature Review. Toxins 13:6, pages 370.
Crossref
Samih Badarny, Raphiq Ibrahim, Zvi Susel, Adnan Zaina, Rema Nasar & Yazid Badarny. (2021) Long-term stable efficacy of botulinum toxin A in facial movement disorders with no need for increasing dose. Medicine 100:25, pages e26481.
Crossref
Raja Mehanna & Joseph Jankovic. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity 1 48 .
Pawel Miotla & Tomasz Rechberger. 2021. Pelvic Floor Disorders. Pelvic Floor Disorders 365 373 .
Petros Sountoulides, Evangelos N. Symeonidis, Nikolaos Pyrgidis & Luca Cindolo. (2020) Interactions between Drugs and Surgery in the Treatment of LUTS and Advanced Renal Cancer. Current Drug Targets 21:15, pages 1512-1514.
Crossref
Uwe Walter, Christopher MühlenhoffReiner BeneckeDirk Dressler, Eilhard MixJanes AltMatthias Wittstock, Ales Dudesek, Alexander Storch & Christoph Kamm. (2020) Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy. Neurology 94:20.
Crossref
Roberto Eleopra, Sara Rinaldo, Cesare Montecucco, Ornella Rossetto & Grazia Devigili. (2020) Clinical duration of action of different botulinum toxin types in humans. Toxicon 179, pages 84-91.
Crossref
Steven Kirshblum, Ryan Solinsky, Neil Jasey, Stephen Hampton, Michelle Didesch, Benjamin Seidel & Amanda Botticello. (2020) Adverse Event Profiles of High Dose Botulinum Toxin Injections for Spasticity. PM&R 12:4, pages 349-355.
Crossref
Gongwei Jia, Jingxi Ma, Sanrong Wang, Dandong Wu, Botao Tan, Ying Yin, Lang Jia & Li Cheng. (2020) Long-term Effects of Extracorporeal Shock Wave Therapy on Poststroke Spasticity: A Meta-analysis of Randomized Controlled Trials. Journal of Stroke and Cerebrovascular Diseases 29:3, pages 104591.
Crossref
N.E. Manturova, E.A. Chaikovskaya & S.L. Timerbayeva. (2020) Botulinum toxin therapy: what do we have and what do we see on the horizon?. Plasticheskaya khirurgiya i esteticheskaya meditsina:2, pages 70.
Crossref
Steven Bellows & Joseph Jankovic. (2019) Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 11:9, pages 491.
Crossref
Laure Mathevon, Arnaud Declemy, Isabelle Laffont & Dominic Perennou. (2019) Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review. Annals of Physical and Rehabilitation Medicine 62:4, pages 241-251.
Crossref
Ryan Solinsky & Steven C. Kirshblum. (2019) Quantifying and Reducing Retained Botulinum Toxin Postinjection. PM&R 11:1, pages 33-37.
Crossref
Talar Tejirian & Louise Yeung. 2019. The SAGES Manual of Hernia Surgery. The SAGES Manual of Hernia Surgery 307 316 .
Talar Tejirian & Louise Yeung. 2019. Robotic Assisted Hernia Repair. Robotic Assisted Hernia Repair 231 242 .
Dirk Dressler. 2021. Botulinum Toxin Therapy. Botulinum Toxin Therapy 93 106 .
Dirk Dressler, Lizhen Pan & Fereshte Adib Saberi. (2018) Antibody-induced failure of botulinum toxin therapy: re-start with low-antigenicity drugs offers a new treatment opportunity. Journal of Neural Transmission 125:10, pages 1481-1486.
Crossref
Joseph Jankovic. (2018) An update on new and unique uses of botulinum toxin in movement disorders. Toxicon 147, pages 84-88.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.